76 related articles for article (PubMed ID: 6223870)
1. [Hormonal contraception with marvelon. Experiences with marvelon in gynecologic practice--a multicenter study by 265 gynecologists on over 26,000 women].
Geissler KH
Fortschr Med; 1983 Jun; 101(22):1060-4. PubMed ID: 6223870
[No Abstract] [Full Text] [Related]
2. A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon).
Ismail MT
Malays J Reprod Health; 1994 Jun; 12(1):43-8. PubMed ID: 12320338
[TBL] [Abstract][Full Text] [Related]
3. [Marvelon. A contraceptive pill with desogestrel, a new gestagenic substance].
Felding IC; Mikkelsen AL
Ugeskr Laeger; 1985 Oct; 147(42):3330-2. PubMed ID: 2934882
[No Abstract] [Full Text] [Related]
4. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
5. Desogestrel-containing oral contraceptives and blood pressure.
Dieben TO; van Beek A
Arzneimittelforschung; 1986 Nov; 36(11):1678-80. PubMed ID: 2949757
[TBL] [Abstract][Full Text] [Related]
6. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
Weijers MJ
Clin Ther; 1982; 4(5):359-66. PubMed ID: 6461412
[TBL] [Abstract][Full Text] [Related]
8. [Current monophasic hormonal contraception].
Chernev T; Ivanov S; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(2):9-11. PubMed ID: 9859526
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal contraception has no effect on the atherogenicity of blood lipids: results of a prospective open-label multicenter study in 1321 patients].
Kunz J; Jaeger A
Praxis (Bern 1994); 1996 Jan; 85(1-2):3-8. PubMed ID: 8571024
[TBL] [Abstract][Full Text] [Related]
11. Desogestrel and ethinyloestradiol.
Haspels AA; Weyers WJ
IPPF Med Bull; 1983 Aug; 17(4):3-4. PubMed ID: 12279590
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
13. A randomised comparative study of Triquilar versus Marvelon: the Malaysian experience.
Ismail MT
Malays J Reprod Health; 1991 Jun; 9(1):9-17. PubMed ID: 12317444
[TBL] [Abstract][Full Text] [Related]
14. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
Vree ML; Schmidt J
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observations using the new contraceptive preparation containing gestagen].
Marianowski L; Cyganek A; Grzechocińska B
Wiad Lek; 1994 Oct; 47(19-20):747-9. PubMed ID: 7483621
[TBL] [Abstract][Full Text] [Related]
16. [Marvelon--when adverse effects became marketing arguments].
Fjoerestad I
Tidsskr Nor Laegeforen; 1986 Aug; 106(22):1735-8. PubMed ID: 2946094
[No Abstract] [Full Text] [Related]
17. [Marvelon--when adverse effects become marketing arguments].
Fjaerestad I
Tidsskr Nor Laegeforen; 1986 Aug; 106(23):1865-6. PubMed ID: 2945284
[No Abstract] [Full Text] [Related]
18. [Marvelon--when the adverse effects become a marketing argument].
Hansson V
Tidsskr Nor Laegeforen; 1986 Apr; 106(11):966-8. PubMed ID: 2941893
[No Abstract] [Full Text] [Related]
19. [Role of milligest in clinical practice].
Iakov B
Akush Ginekol (Sofiia); 2008; 47 Suppl 1():46-9. PubMed ID: 18935858
[No Abstract] [Full Text] [Related]
20. Marvelon--an OC with a new progestagen.
Drug Ther Bull; 1984 Sep; 22(18):69-70. PubMed ID: 6236963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
